Latham & Watkins and Mazanti-Andersen acted as legal advisors to Ascendis on the transaction, while Goodwin Procter, Kromann Reumert and Fenwick & West acted as legal...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Oaktree on the financing. Harrow (Nasdaq: HROW) announced that it has entered into a $100 million secured credit financing agreement with funds...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented InBrace in the transaction. Horizon Technology Finance Corporation (NASDAQ: HRZN) (Horizon) has announced the close of a US$45 million growth facility...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented HilleVax, while Davis Polk advised the joint book-running managers in the IPO. HilleVax, Inc., a clinical-stage biopharmaceutical company focused on developing and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Innocoll Biotherapeutics in the transaction. Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, has announced the successful...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Tailwind Two and Akin Gump Strauss Hauer & Feld advised Terran Orbital on the deal. Latham & Watkins represented Francisco Partners. Tailwind...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Aspiration, while White & Case represented InterPrivate III in the transaction. Sidley Austin acted as legal advisor to the placement agents. Aspiration Partners,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented System1 and certain key shareholders of System1. System1, a leading omnichannel customer acquisition platform, and Trebia Acquisition Corp. (NYSE: TREB), a special...
You must be a Standard 1 Year member to access this content.
